Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7186322 | 0.70 | KMT2A (0.45) | ALDH1A1NPC1 | |
| SCHEMBL8845829 | 0.67 | KMT2A (0.42) | ALDH1A1NPC1 | |
| SCHEMBL14225456 | 0.66 | ALDH1A1 (0.36) | ALDH1A1CYP1A2CYP2C19NPC1 | |
| SCHEMBL14022377 | 0.63 | NPC1 (0.41) | ALDH1A1CYP1A2CYP2C19NPC1 | |
| SCHEMBL9367623 | 0.60 | AGTR1 (0.38) | ALDH1A1CYP1A2CYP2C19 | |
| SCHEMBL31434856 | 0.60 | NPC1 (0.73) | ALDH1A1CYP1A2CYP2C19NPC1 | |
| SCHEMBL12419636 | 0.60 | TSHR (0.68) | ALDH1A1CYP1A2CYP2C19NPC1 | |
| SCHEMBL19736713 | 0.59 | NPC1 (0.48) | ALDH1A1NPC1 | |
| SCHEMBL27598109 | 0.59 | KDM4E (0.58) | ALDH1A1CYP2C19NPC1 | |
| SCHEMBL7612576 | 0.59 | ALDH1A1 (0.41) | ALDH1A1CYP1A2CYP2C19NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0758240-B1 | PHARMACEUTICAL FORMULATIONS CONTAINING A BETA-LACTAMASE INHIBITING PENEM IN COMBINATION WITH A BETA-LACTAM ANTIBIOTIC AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS | SMITHKLINE BEECHAM PLC (GB) | 2003-10-29 | — | — | EP | disclosed |
| US-6600035-B1 | Multistage reaction of forming penicillin antibiotics | SMITHKLINE BEECHAM P.L.C. (GB) | 2003-07-29 | — | — | US | disclosed |
| US-6472383-B1 | Pharmaceutical formulations | SMITHKLINE BEECHAM P.L.C. (GB) | 2002-10-29 | — | — | US | disclosed |
| EP-0666862-B1 | 6-(SUBSTITUTED METHYLENE) PENEMS AND INTERMEDIATES | SMITHKLINE BEECHAM PLC (GB) | 2000-04-19 | — | — | EP | disclosed |
| US-6037469-A | BETA LACTAMASE INHIBITOR AND ANTIBACTERIAL; FOR TREATING BACTERIAL INFECTIONS IN HUMANS AND ANIMALS | SMITHKLINE BEECHAM PLC (GB) | 2000-03-14 | — | — | US | disclosed |
| US-5939066-A | TREATING OR PREVENTING A BACTERIAL INFECTION BY ADMINISTERING A LACTAMASE INHIBITORY EFFECTIVE AMOUNT OF A PENEM AND A LACTAM ANTIBIOTIC | SMITHKLINE BEECHAM P.L.C. | 1999-08-17 | — | — | US | disclosed |
| US-5911985-A | IN COMBINATION WITH CARRIERS AND A LACTAM ANTIBIOTIC | SMITHKLINE BEECHAM P.L.C. (GB) | 1999-06-15 | — | — | US | disclosed |
| US-5776455-A | PENICILLIN BACTERICIDES | SMITHKLINE BEECHAM P.L.C. (GB) | 1998-07-07 | — | — | US | disclosed |
| EP-0758240-A1 | PHARMACEUTICAL FORMULATIONS CONTAINING A BETA-LACTAMASE INHIBITING PENEM IN COMBINATION WITH A BETA-LACTAM ANTIBIOTIC AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS | SMITHKLINE BEECHAM PLC (GB) | 1997-02-19 | — | — | EP | disclosed |
| US-5602250-A | ANTIBIOTICS, BETA-LACTAMASE INHIBITORS | SMITHKLINE BEECHAM P.L.C. (GB) | 1997-02-11 | — | — | US | disclosed |
| WO-1995028935-A1 | PHARMACEUTICAL FORMULATIONS CONTAINING A BETA-LACTAMASE INHIBITING PENEM IN COMBINATION WITH A BETA-LACTAM ANTIBIOTIC AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS | SMITHKLINE BEECHAM PLC (GB) | 1995-11-02 | — | — | WO | disclosed |
| WO-1994010178-A1 | 6-(SUBSTITUTED METHYLENE) PENEMS AND INTERMEDIATES | SMITHKLINE BEECHAM P L C (GB) | 1994-05-11 | — | — | WO | disclosed |